Indianapolis-based Eli Lilly announced Friday its agreement to buy biopharmaceutical company Dermira. Lilly will acquire the California-based company for a little more than $1 billion.

Dermira was founded about a decade ago and sells dermatology drugs to treat conditions including eczema and excessive sweating.